Tofacitinib Keto Impurity
CAT No: o2h-T066057
CAS No: 1236267-27-8
Mol.F. : C16H20N6O2
Mol.Wt. : 328.4
Tofacitinib Keto Impurity
| CAT No | o2h-T066057 |
|---|---|
| CAS No | 1236267-27-8 |
| Mol.F. | C16H20N6O2 |
| Mol.Wt. | 328.4 |
Tofacitinib Citrate
CAT No: o2h-T066001
CAS No: 540737-29-9
Mol.F. : C16H20N6O : C6H8O7
Mol.Wt. : 312.4 : 192.1
Tofacitinib Citrate
| CAT No | o2h-T066001 |
|---|---|
| CAS No | 540737-29-9 |
| Mol.F. | C16H20N6O : C6H8O7 |
| Mol.Wt. | 312.4 : 192.1 |
Tofacitinib
CAT No: o2h-T066000
CAS No: 477600-75-2
Mol.F. : C16H20N6O
Mol.Wt. : 312.4
Tofacitinib
| CAT No | o2h-T066000 |
|---|---|
| CAS No | 477600-75-2 |
| Mol.F. | C16H20N6O |
| Mol.Wt. | 312.4 |
Tofacitinib Impurity C Citrate
CAT No: o2h-T066004
CAS No: 2174011-55-1
Mol.F. : C16H20N6O. C6H8O7
Mol.Wt. : 312.4 : 192.1
Tofacitinib Impurity C Citrate
| CAT No | o2h-T066004 |
|---|---|
| CAS No | 2174011-55-1 |
| Mol.F. | C16H20N6O. C6H8O7 |
| Mol.Wt. | 312.4 : 192.1 |
Tofacitinib Impurity B
CAT No: o2h-T066003
CAS No: 1092578-48-7
Mol.F. : C16H20N6O
Mol.Wt. : 312.4
Tofacitinib Impurity B
| CAT No | o2h-T066003 |
|---|---|
| CAS No | 1092578-48-7 |
| Mol.F. | C16H20N6O |
| Mol.Wt. | 312.4 |
Tofacitinib Impurity A
CAT No: o2h-T066002
CAS No: 1092578-46-5
Mol.F. : C16H20N6O
Mol.Wt. : 312.4
Tofacitinib Impurity A
| CAT No | o2h-T066002 |
|---|---|
| CAS No | 1092578-46-5 |
| Mol.F. | C16H20N6O |
| Mol.Wt. | 312.4 |
Tofacitinib Impurity F
CAT No: o2h-T066005
CAS No: 384338-23-2
Mol.F. : C14H22N2
Mol.Wt. : 218.3
Tofacitinib Impurity F
| CAT No | o2h-T066005 |
|---|---|
| CAS No | 384338-23-2 |
| Mol.F. | C14H22N2 |
| Mol.Wt. | 218.3 |
Tofacitinib Impurity K
CAT No: o2h-T066008
CAS No: 2328165-36-0
Mol.F. : C16H21N5O3
Mol.Wt. : 331.4
Tofacitinib Impurity K
| CAT No | o2h-T066008 |
|---|---|
| CAS No | 2328165-36-0 |
| Mol.F. | C16H21N5O3 |
| Mol.Wt. | 331.4 |
Tofacitinib Impurity J
CAT No: o2h-T066007
CAS No: N/A
Mol.F. : C14H22N2 : 2(HCl)
Mol.Wt. : 218.3 : 2(36.5)
Tofacitinib Impurity J
| CAT No | o2h-T066007 |
|---|---|
| CAS No | N/A |
| Mol.F. | C14H22N2 : 2(HCl) |
| Mol.Wt. | 218.3 : 2(36.5) |
Tofacitinib Impurity I
CAT No: o2h-T066006
CAS No: N/A
Mol.F. : C14H22N2 : 2(HCl)
Mol.Wt. : 218.3 : 2(36.5)
Tofacitinib Impurity I
| CAT No | o2h-T066006 |
|---|---|
| CAS No | N/A |
| Mol.F. | C14H22N2 : 2(HCl) |
| Mol.Wt. | 218.3 : 2(36.5) |
Tofacitinib Impurity L
CAT No: o2h-T066009
CAS No: 1675248-19-7
Mol.F. : C16H22N6O2
Mol.Wt. : 330.4
Tofacitinib Impurity L
| CAT No | o2h-T066009 |
|---|---|
| CAS No | 1675248-19-7 |
| Mol.F. | C16H22N6O2 |
| Mol.Wt. | 330.4 |
Tofacitinib Impurity O
CAT No: o2h-T066012
CAS No: 477600-73-0
Mol.F. : C20H25N5
Mol.Wt. : 335.5
Tofacitinib Impurity O
| CAT No | o2h-T066012 |
|---|---|
| CAS No | 477600-73-0 |
| Mol.F. | C20H25N5 |
| Mol.Wt. | 335.5 |
Tofacitinib Impurity N
CAT No: o2h-T066011
CAS No: 1260614-73-0
Mol.F. : C13H19N5
Mol.Wt. : 245.3
Tofacitinib Impurity N
| CAT No | o2h-T066011 |
|---|---|
| CAS No | 1260614-73-0 |
| Mol.F. | C13H19N5 |
| Mol.Wt. | 245.3 |
Tofacitinib Impurity M
CAT No: o2h-T066010
CAS No: 477600-74-1
Mol.F. : C13H19N5
Mol.Wt. : 245.3
Tofacitinib Impurity M
| CAT No | o2h-T066010 |
|---|---|
| CAS No | 477600-74-1 |
| Mol.F. | C13H19N5 |
| Mol.Wt. | 245.3 |
Tofacitinib Impurity Q
CAT No: o2h-T066014
CAS No: 3680-69-1
Mol.F. : C6H4ClN3
Mol.Wt. : 153.6
Tofacitinib Impurity Q
| CAT No | o2h-T066014 |
|---|---|
| CAS No | 3680-69-1 |
| Mol.F. | C6H4ClN3 |
| Mol.Wt. | 153.6 |
Tofacitinib Impurity P
CAT No: o2h-T066013
CAS No: 1252883-90-1
Mol.F. : C20H25N5
Mol.Wt. : 335.5
Tofacitinib Impurity P
| CAT No | o2h-T066013 |
|---|---|
| CAS No | 1252883-90-1 |
| Mol.F. | C20H25N5 |
| Mol.Wt. | 335.5 |
Tofacitinib Impurity R
CAT No: o2h-T066015
CAS No: 479633-63-1
Mol.F. : C13H10ClN3O2S
Mol.Wt. : 307.8
Tofacitinib Impurity R
| CAT No | o2h-T066015 |
|---|---|
| CAS No | 479633-63-1 |
| Mol.F. | C13H10ClN3O2S |
| Mol.Wt. | 307.8 |
Tofacitinib Impurity U
CAT No: o2h-T066018
CAS No: 1616760-97-4
Mol.F. : C13H18ClN5
Mol.Wt. : 297.8
Tofacitinib Impurity U
| CAT No | o2h-T066018 |
|---|---|
| CAS No | 1616760-97-4 |
| Mol.F. | C13H18ClN5 |
| Mol.Wt. | 297.8 |
Tofacitinib Impurity T
CAT No: o2h-T066017
CAS No: 2504210-31-3
Mol.F. : C16H18N6O
Mol.Wt. : 310.4
Tofacitinib Impurity T
| CAT No | o2h-T066017 |
|---|---|
| CAS No | 2504210-31-3 |
| Mol.F. | C16H18N6O |
| Mol.Wt. | 310.4 |
Tofacitinib Impurity S
CAT No: o2h-T066016
CAS No: 923036-30-0
Mol.F. : C27H31N5O2S
Mol.Wt. : 489.6
Tofacitinib Impurity S
| CAT No | o2h-T066016 |
|---|---|
| CAS No | 923036-30-0 |
| Mol.F. | C27H31N5O2S |
| Mol.Wt. | 489.6 |
Tofacitinib Impurity V
CAT No: o2h-T066019
CAS No: 1616761-00-2
Mol.F. : C16H19ClN6O
Mol.Wt. : 346.8
Tofacitinib Impurity V
| CAT No | o2h-T066019 |
|---|---|
| CAS No | 1616761-00-2 |
| Mol.F. | C16H19ClN6O |
| Mol.Wt. | 346.8 |
Tofacitinib Impurity W
CAT No: o2h-T066020
CAS No: 2504210-32-4
Mol.F. : C13H18ClN5
Mol.Wt. : 279.8
Tofacitinib Impurity W
| CAT No | o2h-T066020 |
|---|---|
| CAS No | 2504210-32-4 |
| Mol.F. | C13H18ClN5 |
| Mol.Wt. | 279.8 |
Tofacitinib Impurity X
CAT No: o2h-T066021
CAS No: 2097982-05-1
Mol.F. : C13H19N5
Mol.Wt. : 245.3
Tofacitinib Impurity X
| CAT No | o2h-T066021 |
|---|---|
| CAS No | 2097982-05-1 |
| Mol.F. | C13H19N5 |
| Mol.Wt. | 245.3 |
Tofacitinib Related Compound 1
CAT No: o2h-T066024
CAS No: 2504210-30-2
Mol.F. : C16H22N6O2
Mol.Wt. : 330.4
Tofacitinib Related Compound 1
| CAT No | o2h-T066024 |
|---|---|
| CAS No | 2504210-30-2 |
| Mol.F. | C16H22N6O2 |
| Mol.Wt. | 330.4 |
Tofacitinib Impurity Z
CAT No: o2h-T066023
CAS No: 477600-76-3
Mol.F. : C15H21N5O
Mol.Wt. : 287.4
Tofacitinib Impurity Z
| CAT No | o2h-T066023 |
|---|---|
| CAS No | 477600-76-3 |
| Mol.F. | C15H21N5O |
| Mol.Wt. | 287.4 |
Tofacitinib Impurity Y
CAT No: o2h-T066022
CAS No: 2227197-38-6
Mol.F. : C14H21N5
Mol.Wt. : 259.4
Tofacitinib Impurity Y
| CAT No | o2h-T066022 |
|---|---|
| CAS No | 2227197-38-6 |
| Mol.F. | C14H21N5 |
| Mol.Wt. | 259.4 |
Tofacitinib Related Compound 2 HCl
CAT No: o2h-T066025
CAS No: 1640971-87-4
Mol.F. : C10H17N3O : HCl
Mol.Wt. : 195.3 : 36.5
Tofacitinib Related Compound 2 HCl
| CAT No | o2h-T066025 |
|---|---|
| CAS No | 1640971-87-4 |
| Mol.F. | C10H17N3O : HCl |
| Mol.Wt. | 195.3 : 36.5 |
Tofacitinib Related Compound 8
CAT No: o2h-T066029
CAS No: 2504210-41-5
Mol.F. : C29H38N10O2
Mol.Wt. : 558.7
Tofacitinib Related Compound 8
| CAT No | o2h-T066029 |
|---|---|
| CAS No | 2504210-41-5 |
| Mol.F. | C29H38N10O2 |
| Mol.Wt. | 558.7 |
Tofacitinib Related Compound 6
CAT No: o2h-T066028
CAS No: 2459302-77-1
Mol.F. : C19H21N7O2
Mol.Wt. : 379.4
Tofacitinib Related Compound 6
| CAT No | o2h-T066028 |
|---|---|
| CAS No | 2459302-77-1 |
| Mol.F. | C19H21N7O2 |
| Mol.Wt. | 379.4 |
Tofacitinib Related Compound 4
CAT No: o2h-T066027
CAS No: 1092578-43-2
Mol.F. : C16H20N6O
Mol.Wt. : 312.4
Tofacitinib Related Compound 4
| CAT No | o2h-T066027 |
|---|---|
| CAS No | 1092578-43-2 |
| Mol.F. | C16H20N6O |
| Mol.Wt. | 312.4 |
Tofacitinib Related Compound 3
CAT No: o2h-T066026
CAS No: N/A
Mol.F. : C13H18N4O2
Mol.Wt. : 262.3
Tofacitinib Related Compound 3
| CAT No | o2h-T066026 |
|---|---|
| CAS No | N/A |
| Mol.F. | C13H18N4O2 |
| Mol.Wt. | 262.3 |
Tofacitinib Related Compound 11
CAT No: o2h-T066032
CAS No: 1640971-60-3
Mol.F. : C14H20N6O
Mol.Wt. : 288.4
Tofacitinib Related Compound 11
| CAT No | o2h-T066032 |
|---|---|
| CAS No | 1640971-60-3 |
| Mol.F. | C14H20N6O |
| Mol.Wt. | 288.4 |
Tofacitinib Related Compound 10
CAT No: o2h-T066031
CAS No: 2374700-39-5
Mol.F. : C13H19N5
Mol.Wt. : 245.3
Tofacitinib Related Compound 10
| CAT No | o2h-T066031 |
|---|---|
| CAS No | 2374700-39-5 |
| Mol.F. | C13H19N5 |
| Mol.Wt. | 245.3 |
Tofacitinib Related Compound 9
CAT No: o2h-T066030
CAS No: 2459302-78-2
Mol.F. : C34H45N7
Mol.Wt. : 551.8
Tofacitinib Related Compound 9
| CAT No | o2h-T066030 |
|---|---|
| CAS No | 2459302-78-2 |
| Mol.F. | C34H45N7 |
| Mol.Wt. | 551.8 |
Tofacitinib Related Compound 13
CAT No: o2h-T066034
CAS No: 1092578-45-4
Mol.F. : C20H25N5
Mol.Wt. : 335.5
Tofacitinib Related Compound 13
| CAT No | o2h-T066034 |
|---|---|
| CAS No | 1092578-45-4 |
| Mol.F. | C20H25N5 |
| Mol.Wt. | 335.5 |
Tofacitinib Related Compound 12
CAT No: o2h-T066033
CAS No: 2459302-80-6
Mol.F. : C20H25N5
Mol.Wt. : 335.5
Tofacitinib Related Compound 12
| CAT No | o2h-T066033 |
|---|---|
| CAS No | 2459302-80-6 |
| Mol.F. | C20H25N5 |
| Mol.Wt. | 335.5 |
Tofacitinib Related Compound 15
CAT No: o2h-T066036
CAS No: N/A
Mol.F. : C15H21N5O
Mol.Wt. : 287.4
Tofacitinib Related Compound 15
| CAT No | o2h-T066036 |
|---|---|
| CAS No | N/A |
| Mol.F. | C15H21N5O |
| Mol.Wt. | 287.4 |
Tofacitinib Related Compound 14
CAT No: o2h-T066035
CAS No: 2227199-28-0
Mol.F. : C14H19N5O
Mol.Wt. : 273.3
Tofacitinib Related Compound 14
| CAT No | o2h-T066035 |
|---|---|
| CAS No | 2227199-28-0 |
| Mol.F. | C14H19N5O |
| Mol.Wt. | 273.3 |
Tofacitinib Related Compound 18
CAT No: o2h-T066039
CAS No: 1092578-44-3
Mol.F. : C27H31N5O2S
Mol.Wt. : 489.6
Tofacitinib Related Compound 18
| CAT No | o2h-T066039 |
|---|---|
| CAS No | 1092578-44-3 |
| Mol.F. | C27H31N5O2S |
| Mol.Wt. | 489.6 |
Tofacitinib Related Compound 17
CAT No: o2h-T066038
CAS No: 2056104-91-5
Mol.F. : C27H31N5O2S
Mol.Wt. : 489.6
Tofacitinib Related Compound 17
| CAT No | o2h-T066038 |
|---|---|
| CAS No | 2056104-91-5 |
| Mol.F. | C27H31N5O2S |
| Mol.Wt. | 489.6 |
Tofacitinib Related Compound 16
CAT No: o2h-T066037
CAS No: N/A
Mol.F. : C15H23N5
Mol.Wt. : 273.4
Tofacitinib Related Compound 16
| CAT No | o2h-T066037 |
|---|---|
| CAS No | N/A |
| Mol.F. | C15H23N5 |
| Mol.Wt. | 273.4 |
Tofacitinib Related Compound 21
CAT No: o2h-T066042
CAS No: 1809002-40-1
Mol.F. : C16H22N6O : C6H8O7
Mol.Wt. : 314.4 : 192.1
Tofacitinib Related Compound 21
| CAT No | o2h-T066042 |
|---|---|
| CAS No | 1809002-40-1 |
| Mol.F. | C16H22N6O : C6H8O7 |
| Mol.Wt. | 314.4 : 192.1 |
Tofacitinib Related Compound 20
CAT No: o2h-T066041
CAS No: 2259288-22-5
Mol.F. : C23H26N6O3S
Mol.Wt. : 466.6
Tofacitinib Related Compound 20
| CAT No | o2h-T066041 |
|---|---|
| CAS No | 2259288-22-5 |
| Mol.F. | C23H26N6O3S |
| Mol.Wt. | 466.6 |
Tofacitinib Related Compound 19
CAT No: o2h-T066040
CAS No: 2028267-73-2
Mol.F. : C16H20N6O2
Mol.Wt. : 328.4
Tofacitinib Related Compound 19
| CAT No | o2h-T066040 |
|---|---|
| CAS No | 2028267-73-2 |
| Mol.F. | C16H20N6O2 |
| Mol.Wt. | 328.4 |
Tofacitinib Related Compound 24
CAT No: o2h-T066044
CAS No: 2459302-82-8
Mol.F. : C19H23N7O2
Mol.Wt. : 381.4
Tofacitinib Related Compound 24
| CAT No | o2h-T066044 |
|---|---|
| CAS No | 2459302-82-8 |
| Mol.F. | C19H23N7O2 |
| Mol.Wt. | 381.4 |
Tofacitinib Related Compound 23 DiHCl
CAT No: o2h-T066043
CAS No: N/A
Mol.F. : C13H21N5.2 HCl
Mol.Wt. : 247.4 : 2(36.5)
Tofacitinib Related Compound 23 DiHCl
| CAT No | o2h-T066043 |
|---|---|
| CAS No | N/A |
| Mol.F. | C13H21N5.2 HCl |
| Mol.Wt. | 247.4 : 2(36.5) |
Tofacitinib Related Compound 27
CAT No: o2h-T066047
CAS No: N/A
Mol.F. : C13H18N4O2
Mol.Wt. : 262.3
Tofacitinib Related Compound 27
| CAT No | o2h-T066047 |
|---|---|
| CAS No | N/A |
| Mol.F. | C13H18N4O2 |
| Mol.Wt. | 262.3 |
Tofacitinib Related Compound 26 HCl
CAT No: o2h-T066046
CAS No: 1206824-85-2
Mol.F. : C10H17N3O : HCl
Mol.Wt. : 195.3 : 36.5
Tofacitinib Related Compound 26 HCl
| CAT No | o2h-T066046 |
|---|---|
| CAS No | 1206824-85-2 |
| Mol.F. | C10H17N3O : HCl |
| Mol.Wt. | 195.3 : 36.5 |
Tofacitinib Related Compound 25
CAT No: o2h-T066045
CAS No: 2504210-33-5
Mol.F. : C27H31N5OS
Mol.Wt. : 473.7
Tofacitinib Related Compound 25
| CAT No | o2h-T066045 |
|---|---|
| CAS No | 2504210-33-5 |
| Mol.F. | C27H31N5OS |
| Mol.Wt. | 473.7 |
Tofacitinib Related Compound 29
CAT No: o2h-T066049
CAS No: 134965-85-8
Mol.F. : C12H7ClN6
Mol.Wt. : 270.7
Tofacitinib Related Compound 29
| CAT No | o2h-T066049 |
|---|---|
| CAS No | 134965-85-8 |
| Mol.F. | C12H7ClN6 |
| Mol.Wt. | 270.7 |
Tofacitinib Related Compound 28 (rac-trans-Tofacitinib)
CAT No: o2h-T066048
CAS No: N/A
Mol.F. : C16H20N6O
Mol.Wt. : 312.4
Tofacitinib Related Compound 28 (rac-trans-Tofacitinib)
| CAT No | o2h-T066048 |
|---|---|
| CAS No | N/A |
| Mol.F. | C16H20N6O |
| Mol.Wt. | 312.4 |
Tofacitinib Related Impurity (PF-05579970)
CAT No: o2h-T066050
CAS No: N/A
Mol.F. : C15H21N5O
Mol.Wt. : 287.4
Tofacitinib Related Impurity (PF-05579970)
| CAT No | o2h-T066050 |
|---|---|
| CAS No | N/A |
| Mol.F. | C15H21N5O |
| Mol.Wt. | 287.4 |
Tofacitinib Impurity (N-Des-(2-Cyanide-acetyl)-(3S,4R))
CAT No: o2h-T066052
CAS No: 2378663-15-9
Mol.F. : C13H19N5
Mol.Wt. : 245.3
Tofacitinib Impurity (N-Des-(2-Cyanide-acetyl)-(3S,4R))
| CAT No | o2h-T066052 |
|---|---|
| CAS No | 2378663-15-9 |
| Mol.F. | C13H19N5 |
| Mol.Wt. | 245.3 |
rac-Tofacitinib (Mixture of Diastereomers)
CAT No: o2h-T066051
CAS No: 344418-92-4
Mol.F. : C16H20N6O
Mol.Wt. : 312.4
rac-Tofacitinib (Mixture of Diastereomers)
| CAT No | o2h-T066051 |
|---|---|
| CAS No | 344418-92-4 |
| Mol.F. | C16H20N6O |
| Mol.Wt. | 312.4 |
Tofacitinib Impurity (N-Des-(2-Cyanide-acetyl)-(3R,4S))
CAT No: o2h-T066053
CAS No: 2459302-75-9
Mol.F. : C13H19N5
Mol.Wt. : 245.3
Tofacitinib Impurity (N-Des-(2-Cyanide-acetyl)-(3R,4S))
| CAT No | o2h-T066053 |
|---|---|
| CAS No | 2459302-75-9 |
| Mol.F. | C13H19N5 |
| Mol.Wt. | 245.3 |
Tofacitinib N-hydroxy Impurity
CAT No: o2h-T066054
CAS No: 2459302-76-0
Mol.F. : C13H19N5O
Mol.Wt. : 261.3
Tofacitinib N-hydroxy Impurity
| CAT No | o2h-T066054 |
|---|---|
| CAS No | 2459302-76-0 |
| Mol.F. | C13H19N5O |
| Mol.Wt. | 261.3 |
7-Deazapurine
CAT No: o2h-T066056
CAS No: 271-70-5
Mol.F. : C6H7N3
Mol.Wt. : 121.1
7-Deazapurine
| CAT No | o2h-T066056 |
|---|---|
| CAS No | 271-70-5 |
| Mol.F. | C6H7N3 |
| Mol.Wt. | 121.1 |
1-Benzyl-4-methylpiperidin-3-one
CAT No: o2h-T066055
CAS No: 32018-96-5
Mol.F. : C13H17NO
Mol.Wt. : 203.3
1-Benzyl-4-methylpiperidin-3-one
| CAT No | o2h-T066055 |
|---|---|
| CAS No | 32018-96-5 |
| Mol.F. | C13H17NO |
| Mol.Wt. | 203.3 |
Tofacitinib Citrate Recamic Mixture
CAT No: o2h-T066059
CAS No: N/A
Mol.F. : C16H20N6O
Mol.Wt. : 312.4
Tofacitinib Citrate Recamic Mixture
| CAT No | o2h-T066059 |
|---|---|
| CAS No | N/A |
| Mol.F. | C16H20N6O |
| Mol.Wt. | 312.4 |
Tofacitinib Hydroxy Impurity
CAT No: o2h-T066058
CAS No: N/A
Mol.F. : C16H20N6O2
Mol.Wt. : 328.4
Tofacitinib Hydroxy Impurity
| CAT No | o2h-T066058 |
|---|---|
| CAS No | N/A |
| Mol.F. | C16H20N6O2 |
| Mol.Wt. | 328.4 |
Tofacitinib Mixure of Diastereomers
CAT No: o2h-T066060
CAS No: 2664002-63-3
Mol.F. : C16H20N6O : C6H8O7
Mol.Wt. : 312.4 : 192.1
Tofacitinib Mixure of Diastereomers
| CAT No | o2h-T066060 |
|---|---|
| CAS No | 2664002-63-3 |
| Mol.F. | C16H20N6O : C6H8O7 |
| Mol.Wt. | 312.4 : 192.1 |
Tofacitinib Related Substance 2
CAT No: o2h-T066063
CAS No: 2101951-13-5
Mol.F. : C16H22N6O3
Mol.Wt. : 346.4
Tofacitinib Related Substance 2
| CAT No | o2h-T066063 |
|---|---|
| CAS No | 2101951-13-5 |
| Mol.F. | C16H22N6O3 |
| Mol.Wt. | 346.4 |
Tofacitinib Related Substance 1
CAT No: o2h-T066062
CAS No: 2101958-24-9
Mol.F. : C16H22N6O3
Mol.Wt. : 346.4
Tofacitinib Related Substance 1
| CAT No | o2h-T066062 |
|---|---|
| CAS No | 2101958-24-9 |
| Mol.F. | C16H22N6O3 |
| Mol.Wt. | 346.4 |
Tofacitinib Diastereomer 1 and 2
CAT No: o2h-T066061
CAS No: N/A
Mol.F. : C16H20N6O : C6H8O7
Mol.Wt. : 312.4 : 192.1
Tofacitinib Diastereomer 1 and 2
| CAT No | o2h-T066061 |
|---|---|
| CAS No | N/A |
| Mol.F. | C16H20N6O : C6H8O7 |
| Mol.Wt. | 312.4 : 192.1 |
Tofacitinib Related Substance 4
CAT No: o2h-T066064
CAS No: N/A
Mol.F. : C18H26N6O2
Mol.Wt. : 358.4
Tofacitinib Related Substance 4
| CAT No | o2h-T066064 |
|---|---|
| CAS No | N/A |
| Mol.F. | C18H26N6O2 |
| Mol.Wt. | 358.4 |
Tofacitinib Dihydro Impurity
CAT No: o2h-T066067
CAS No: 1640972-35-5
Mol.F. : C16H22N6O
Mol.Wt. : 314.4
Tofacitinib Dihydro Impurity
| CAT No | o2h-T066067 |
|---|---|
| CAS No | 1640972-35-5 |
| Mol.F. | C16H22N6O |
| Mol.Wt. | 314.4 |
Tofacitinib Related Substance 6
CAT No: o2h-T066066
CAS No: N/A
Mol.F. : C16H22N6O4
Mol.Wt. : 362.4
Tofacitinib Related Substance 6
| CAT No | o2h-T066066 |
|---|---|
| CAS No | N/A |
| Mol.F. | C16H22N6O4 |
| Mol.Wt. | 362.4 |
Tofacitinib Related Substance 5
CAT No: o2h-T066065
CAS No: N/A
Mol.F. : C16H22N6O2
Mol.Wt. : 330.4
Tofacitinib Related Substance 5
| CAT No | o2h-T066065 |
|---|---|
| CAS No | N/A |
| Mol.F. | C16H22N6O2 |
| Mol.Wt. | 330.4 |
Tofacitinib Related Substance 9
CAT No: o2h-T066069
CAS No: N/A
Mol.F. : C21H27N7O3
Mol.Wt. : 425.5
Tofacitinib Related Substance 9
| CAT No | o2h-T066069 |
|---|---|
| CAS No | N/A |
| Mol.F. | C21H27N7O3 |
| Mol.Wt. | 425.5 |
Tofacitinib Related Substance 8
CAT No: o2h-T066068
CAS No: 2101951-20-4
Mol.F. : C16H20N6O2
Mol.Wt. : 328.4
Tofacitinib Related Substance 8
| CAT No | o2h-T066068 |
|---|---|
| CAS No | 2101951-20-4 |
| Mol.F. | C16H20N6O2 |
| Mol.Wt. | 328.4 |
Tofacitinib Related Substance 11
CAT No: o2h-T066071
CAS No: N/A
Mol.F. : C16H19ClN6O
Mol.Wt. : 346.8
Tofacitinib Related Substance 11
| CAT No | o2h-T066071 |
|---|---|
| CAS No | N/A |
| Mol.F. | C16H19ClN6O |
| Mol.Wt. | 346.8 |
Tofacitinib Related Substance 10
CAT No: o2h-T066070
CAS No: N/A
Mol.F. : C32H40N12O2
Mol.Wt. : 624.8
Tofacitinib Related Substance 10
| CAT No | o2h-T066070 |
|---|---|
| CAS No | N/A |
| Mol.F. | C32H40N12O2 |
| Mol.Wt. | 624.8 |
Tofacitinib Impurity 4
CAT No: o2h-T066074
CAS No: 1675248-18-6
Mol.F. : C18H25N5O3
Mol.Wt. : 359.4
Tofacitinib Impurity 4
| CAT No | o2h-T066074 |
|---|---|
| CAS No | 1675248-18-6 |
| Mol.F. | C18H25N5O3 |
| Mol.Wt. | 359.4 |
Tofacitinib Impurity 3
CAT No: o2h-T066073
CAS No: 1206825-36-6
Mol.F. : C13H19N5
Mol.Wt. : 245.3
Tofacitinib Impurity 3
| CAT No | o2h-T066073 |
|---|---|
| CAS No | 1206825-36-6 |
| Mol.F. | C13H19N5 |
| Mol.Wt. | 245.3 |
Tofacitinib Impurity 2
CAT No: o2h-T066072
CAS No: 1640971-51-2
Mol.F. : C16H20N6O2
Mol.Wt. : 328.4
Tofacitinib Impurity 2
| CAT No | o2h-T066072 |
|---|---|
| CAS No | 1640971-51-2 |
| Mol.F. | C16H20N6O2 |
| Mol.Wt. | 328.4 |
Tofacitinib Impurity 5
CAT No: o2h-T066075
CAS No: 1354621-59-2
Mol.F. : C14H22N2
Mol.Wt. : 218.3
Tofacitinib Impurity 5
| CAT No | o2h-T066075 |
|---|---|
| CAS No | 1354621-59-2 |
| Mol.F. | C14H22N2 |
| Mol.Wt. | 218.3 |
Tofacitinib Impurity 8
CAT No: o2h-T066078
CAS No: 1527525-58-1
Mol.F. : C15H18N6O
Mol.Wt. : 298.4
Tofacitinib Impurity 8
| CAT No | o2h-T066078 |
|---|---|
| CAS No | 1527525-58-1 |
| Mol.F. | C15H18N6O |
| Mol.Wt. | 298.4 |
Tofacitinib Impurity 7
CAT No: o2h-T066077
CAS No: N/A
Mol.F. : C13H19N5
Mol.Wt. : 245.3
Tofacitinib Impurity 7
| CAT No | o2h-T066077 |
|---|---|
| CAS No | N/A |
| Mol.F. | C13H19N5 |
| Mol.Wt. | 245.3 |
Tofacitinib Impurity 6
CAT No: o2h-T066076
CAS No: N/A
Mol.F. : C19H22N8
Mol.Wt. : 362.4
Tofacitinib Impurity 6
| CAT No | o2h-T066076 |
|---|---|
| CAS No | N/A |
| Mol.F. | C19H22N8 |
| Mol.Wt. | 362.4 |
Tofacitinib Impurity 9
CAT No: o2h-T066079
CAS No: 2382711-65-9
Mol.F. : C34H42N10O2
Mol.Wt. : 622.8
Tofacitinib Impurity 9
| CAT No | o2h-T066079 |
|---|---|
| CAS No | 2382711-65-9 |
| Mol.F. | C34H42N10O2 |
| Mol.Wt. | 622.8 |
Tofacitinib Impurity 28
CAT No: o2h-T066081
CAS No: 2227199-31-5
Mol.F. : C20H29N5O3
Mol.Wt. : 387.5
Tofacitinib Impurity 28
| CAT No | o2h-T066081 |
|---|---|
| CAS No | 2227199-31-5 |
| Mol.F. | C20H29N5O3 |
| Mol.Wt. | 387.5 |
Tofacitinib Impurity 27
CAT No: o2h-T066080
CAS No: N/A
Mol.F. : C23H34N6O3
Mol.Wt. : 442.6
Tofacitinib Impurity 27
| CAT No | o2h-T066080 |
|---|---|
| CAS No | N/A |
| Mol.F. | C23H34N6O3 |
| Mol.Wt. | 442.6 |
Tofacitinib Impurity 31
CAT No: o2h-T066084
CAS No: 344418-61-7
Mol.F. : C15H21N5O
Mol.Wt. : 287.4
Tofacitinib Impurity 31
| CAT No | o2h-T066084 |
|---|---|
| CAS No | 344418-61-7 |
| Mol.F. | C15H21N5O |
| Mol.Wt. | 287.4 |
Tofacitinib Impurity 30
CAT No: o2h-T066083
CAS No: 105-56-6
Mol.F. : C5H7NO2
Mol.Wt. : 113.1
Tofacitinib Impurity 30
| CAT No | o2h-T066083 |
|---|---|
| CAS No | 105-56-6 |
| Mol.F. | C5H7NO2 |
| Mol.Wt. | 113.1 |
Tofacitinib Impurity 29
CAT No: o2h-T066082
CAS No: N/A
Mol.F. : C21H27N7O3
Mol.Wt. : 425.5
Tofacitinib Impurity 29
| CAT No | o2h-T066082 |
|---|---|
| CAS No | N/A |
| Mol.F. | C21H27N7O3 |
| Mol.Wt. | 425.5 |
Tofacitinib Impurity 32
CAT No: o2h-T066085
CAS No: 477600-69-4
Mol.F. : C14H22N2
Mol.Wt. : 218.3
Tofacitinib Impurity 32
| CAT No | o2h-T066085 |
|---|---|
| CAS No | 477600-69-4 |
| Mol.F. | C14H22N2 |
| Mol.Wt. | 218.3 |
Tofacitinib Impurity 33
CAT No: o2h-T066086
CAS No: 16372-08-0
Mol.F. : C6H6ClN3
Mol.Wt. : 155.6
Tofacitinib Impurity 33
| CAT No | o2h-T066086 |
|---|---|
| CAS No | 16372-08-0 |
| Mol.F. | C6H6ClN3 |
| Mol.Wt. | 155.6 |
Tofacitinib Impurity 36
CAT No: o2h-T066089
CAS No: N/A
Mol.F. : C16H20N6O2
Mol.Wt. : 328.4
Tofacitinib Impurity 36
| CAT No | o2h-T066089 |
|---|---|
| CAS No | N/A |
| Mol.F. | C16H20N6O2 |
| Mol.Wt. | 328.4 |
Tofacitinib Impurity 35
CAT No: o2h-T066088
CAS No: 1092578-47-6
Mol.F. : C16H20N6O
Mol.Wt. : 312.4
Tofacitinib Impurity 35
| CAT No | o2h-T066088 |
|---|---|
| CAS No | 1092578-47-6 |
| Mol.F. | C16H20N6O |
| Mol.Wt. | 312.4 |
Tofacitinib Impurity 34
CAT No: o2h-T066087
CAS No: 1111638-10-8
Mol.F. : C5H3ClN4
Mol.Wt. : 154.6
Tofacitinib Impurity 34
| CAT No | o2h-T066087 |
|---|---|
| CAS No | 1111638-10-8 |
| Mol.F. | C5H3ClN4 |
| Mol.Wt. | 154.6 |
Tofacitinib -Dihydro Intermediate
CAT No: o2h-T066091
CAS No: NA
Mol.F. : C13H21N5
Mol.Wt. : 247.35
Tofacitinib -Dihydro Intermediate
| CAT No | o2h-T066091 |
|---|---|
| CAS No | NA |
| Mol.F. | C13H21N5 |
| Mol.Wt. | 247.35 |
Tofacitinib Impurity 40
CAT No: o2h-T066090
CAS No: 477600-70-7
Mol.F. : C14H22N2
Mol.Wt. : 218.3
Tofacitinib Impurity 40
| CAT No | o2h-T066090 |
|---|---|
| CAS No | 477600-70-7 |
| Mol.F. | C14H22N2 |
| Mol.Wt. | 218.3 |
Tofacitinib Impurity 42
CAT No: o2h-T066094
CAS No: NA
Mol.F. : C54H62N10O4S2
Mol.Wt. : 979.28
Tofacitinib Impurity 42
| CAT No | o2h-T066094 |
|---|---|
| CAS No | NA |
| Mol.F. | C54H62N10O4S2 |
| Mol.Wt. | 979.28 |
Tofacitinib Impurity 41
CAT No: o2h-T066093
CAS No: NA
Mol.F. : C28H44N4
Mol.Wt. : 436.69
Tofacitinib Impurity 41
| CAT No | o2h-T066093 |
|---|---|
| CAS No | NA |
| Mol.F. | C28H44N4 |
| Mol.Wt. | 436.69 |
Tofacitinib -Enantiomer intermediate
CAT No: o2h-T066092
CAS No: NA
Mol.F. : C27H31N5O2S
Mol.Wt. : 489.64
Tofacitinib -Enantiomer intermediate
| CAT No | o2h-T066092 |
|---|---|
| CAS No | NA |
| Mol.F. | C27H31N5O2S |
| Mol.Wt. | 489.64 |
N-Nitroso Tofacitinib Impurity 2
CAT No: o2h-T066097
CAS No: NA
Mol.F. : C16H22N6O2
Mol.Wt. : 330.4
N-Nitroso Tofacitinib Impurity 2
| CAT No | o2h-T066097 |
|---|---|
| CAS No | NA |
| Mol.F. | C16H22N6O2 |
| Mol.Wt. | 330.4 |
Tofacitinib N-Nitroso impurity
CAT No: o2h-T066096
CAS No: NA
Mol.F. : C13H18N6O
Mol.Wt. : 274.32
Tofacitinib N-Nitroso impurity
| CAT No | o2h-T066096 |
|---|---|
| CAS No | NA |
| Mol.F. | C13H18N6O |
| Mol.Wt. | 274.32 |
Tofacitinib Impurity 43
CAT No: o2h-T066095
CAS No: NA
Mol.F. : C32H40N12O2
Mol.Wt. : 624.75
Tofacitinib Impurity 43
| CAT No | o2h-T066095 |
|---|---|
| CAS No | NA |
| Mol.F. | C32H40N12O2 |
| Mol.Wt. | 624.75 |
Tofacitinib Desmethyl Nitrosamine impurity
CAT No: o2h-T066099
CAS No: NA
Mol.F. : C15H17N7O2
Mol.Wt. : 327.34
Tofacitinib Desmethyl Nitrosamine impurity
| CAT No | o2h-T066099 |
|---|---|
| CAS No | NA |
| Mol.F. | C15H17N7O2 |
| Mol.Wt. | 327.34 |
N-Nitroso Tofacitinib Impurity 3
CAT No: o2h-T066098
CAS No: NA
Mol.F. : C14H21N3O
Mol.Wt. : 247.34
N-Nitroso Tofacitinib Impurity 3
| CAT No | o2h-T066098 |
|---|---|
| CAS No | NA |
| Mol.F. | C14H21N3O |
| Mol.Wt. | 247.34 |